BrightSpring Health Services, Inc. Common Stock (BTSG) Valuation
Historical valuation analysis based on 500 data points (2024-09-23 to 2026-09-21)
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform del...
BrightSpring Health Services, Inc. Common Stock (BTSG) currently trades at a P/E ratio of 39.89 (historical range: 30.02–76.01, median: 50.35), placing it at the 12th percentile — cheap relative to its history, P/S ratio of 0.91 (range: 0.27–1.18, 82th percentile — expensive relative to its history), EV/EBITDA of 38.03 (range: 27.11–50.20, 49th percentile).
BrightSpring Health Services, Inc. Common Stock trades near its historical valuation range, with most metrics close to their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 39.89 | 30.02 | 50.35 | 76.01 | 12th | cheap relative to its history |
| P/S Ratio | 0.91 | 0.27 | 0.52 | 1.18 | 82th | expensive relative to its history |
| EV/EBITDA | 38.03 | 27.11 | 38.20 | 50.20 | 49th | near its historical average |
| FCF Yield | 0.03 | 0.03 | 0.03 | 0.04 | 60th | near its historical average |
BrightSpring Health Services, Inc. Common Stock (BTSG) Valuation & P/E History
BrightSpring Health Services, Inc. Common Stock (BTSG) is a US-listed stock operating in the Healthcare sector, specifically the Services-Home Health Care Services industry currently trading at $55.86 with a market capitalization of $11.1 billion. This page provides historical valuation analysis for BTSG based on 500 data points covering 2024-09-23 to 2026-09-21. The P/E ratio of 39.89 is below the historical median of 50.35, placing BTSG at the 12th percentile of its valuation range. The P/S ratio of 0.91 compares to a median of 0.52.
BTSG Valuation Metrics & Historical Range
The valuation table above shows BrightSpring Health Services, Inc. Common Stock's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether BTSG is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests BTSG is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for BrightSpring Health Services, Inc. Common Stock.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is BTSG Overvalued or Undervalued?
BrightSpring Health Services, Inc. Common Stock trades near its historical valuation range, with most metrics close to their median levels. The overall valuation percentile of 48 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive BTSG is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full BTSG analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.BTSG trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.